TY  - RPRT
TI  - A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels
AU  - Barfield, R. M.
AU  - Kim, Y. C.
AU  - Chuprakov, S.
AU  - Zhang, F.
AU  - Bauzon, M.
AU  - Ogunkoya, A. O.
AU  - Yeo, D.
AU  - Hickle, C.
AU  - Pegram, M. D.
AU  - Rabuka, D.
AU  - Drake, P. M.
PY  - 2020
DO  - 10.1101/2020.03.13.991448
UR  - https://www.biorxiv.org/content/10.1101/2020.03.13.991448v1
ID  - 10.1101/2020.03.13.991448
ER  -